The People behind the Tiny Revolution
Martha Carlin, CEO
CEO, BioCollective Research and The BioCollective; Investor/advisor, Pure Cultures and Amazigh; Executive Vice President operations, UDR; VP Operations, Ops Technology; Chief Financial Officer, Wentwood Investment Partners; consultant/manager, Arthur Andersen.
Suzanne D. Vernon, PhD.
Chief Scientific Officer, BioCollective Research and The BioCollective; Scientific Director, Solve ME/CFS Initiative; driving force behind creation of SolveCFS BioBank, an integrated patient registry and sample biorepository; author and co-author of more than 90 peer-reviewed publications; Team Leader of the Centers for Disease Control and Prevention.
Jack Gilbert, PhD.
Associate Professor in the Departments of Ecology and Evolution and Surgery; Associate Director, Institute for Genomics and Systems Biology; Group Leader, Microbial Ecology, Argonne National Laboratory; Senior Scientist, Marine Biological Laboratory; Popular Science Top 10 Young Scientists in America and Top 50 Scientists Changing the World
Board of Directors
CEO and founder of We Are Curious, Inc.; co-Founder of 23andMe, Inc.; founded Brainstorm Research Foundation, which focuses on accelerating research in Alzheimer’s disease; developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences; worked at Spotfire helping scientists understand the power of data visualization and at Applied BioSystems during the early days of the human genome project
Founder and chief apostle of InnoThink, a consultancy focused on pharmaceutical innovation; Senior Fellow at FasterCures, a center of the Milken Institute; serves on various boards and advisory bodies, including NCATS, the Institute of Medicine, Glenmark Pharmaceuticals, think tanks and foundations
Mark Muller, PhD.
Founder and CEO of TopoGEN, Inc., a winner of the Edison Prize as most innovative start-up company in Ohio; leading force in successful academic research programs funded by NIH, ACS, NSF and various state and local agencies; founder of biotechnology startups, including Visual Genomics, Methylation Ltd., DNA Protein, Ltd.; past Director of the Cancer Research Consortium of Central Florida; Director of the Experimental Therapeutics Program at The Ohio State University Comprehensive Cancer Center (an NCI designated cancer center); co-founder of the first Department of Molecular Genetics in the U.S. while on faculty at Ohio State University